Is Lineage Cell Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 07:10 PM IST
share
Share Via
As of September 10, 2025, Lineage Cell Therapeutics, Inc. shows a bullish technical trend, supported by positive MACD and moving averages, despite a bearish weekly RSI, and has significantly outperformed the S&P 500 with a year-to-date return of 208.46%.
As of 10 September 2025, the technical trend for Lineage Cell Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. However, the weekly RSI remains bearish, indicating some short-term weakness. The company has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 208.46% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish, with strong indicators driving this sentiment.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Lineage Cell Therapeutics Hits New 52-Week High of $2.09
Nov 04 2025 05:45 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.95
Nov 03 2025 05:00 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.87
Oct 31 2025 04:00 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.85
Oct 15 2025 04:44 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.82
Oct 09 2025 07:58 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.72
Sep 29 2025 02:14 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.64
Sep 24 2025 01:13 PM IST
share
Share Via
Most Read
Why is Bluestone Jewel falling/rising?
1 hour ago
share
Share Via
Why is Borana Weaves falling/rising?
1 hour ago
share
Share Via
Why is Malpani Pipes falling/rising?
1 hour ago
share
Share Via
Why is Sat Kartar falling/rising?
1 hour ago
share
Share Via
Why is Baazar Style falling/rising?
1 hour ago
share
Share Via
Why is Blackbuck falling/rising?
1 hour ago
share
Share Via